Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development
Monday, March 12, 2018LabCorp a leading global life sciences company announced today that its Covance Drug Development Covance business has formed a global immunology and immunotoxicology II unit dedicated to the specific needs of biologic drug development This team bring...
Seattle Genetics Completes Acquisition of Cascadian Therapeutics
Monday, March 12, 2018Seattle Genetics Inc announced it has completed its previously announced acquisition of Cascadian Therapeutics Inc The most advanced program in Cascadian Therapeutics pipeline is tucatinib an investigational oral tyrosine kinase inhibitor TKI that is...
Sanofi Completes Acquisition of Bioverativ Inc.
Friday, March 09, 2018Sanofi announced today the successful completion of its acquisition of Bioverativ Inc Bioverativ for per share in cash The addition of Bioverativ provides us with a strong position in the large and growing hemophilia market and expands our presen...
BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial
Thursday, March 08, 2018BioTime Inc a clinicalstage biotechnology company focused on addressing degenerative diseases today announced that the independent Data Safety Monitoring Board DSMB has approved initiation of the fourth cohort for the ongoing OpRegen clinical trial T...
Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)
Thursday, March 08, 2018Eisai Co Ltd and Merck known as MSD outside the United States and Canada today announced that the companies have agreed upon a strategic collaboration for the worldwide codevelopment and cocommercialization of LENVIMA lenvatinib mesylate an orally av...
Constant Pharmaceuticals, LLC Announces Japanese Patent Issuance for TXA302 in Treatment of Stroke
Wednesday, March 07, 2018Constant Pharmaceuticals LLC a privately held biopharmaceutical company focused on the treatment of stroke recovery today announced that the Japanese Patent Office has issued a patent covering the use of TXA in the treatment of stroke TXA is a propri...
Science 37 and Novartis Sign Strategic Alliance to Advance Decentralized Clinical Trials
Wednesday, March 07, 2018Science a trailblazing company focused on siteless clinical trials announced today a strategic alliance with Novartis that will support the development of its new decentralized clinical trial DCT offerings This threeyear commitment will enable a mor...
GlycoMimetics Announces Design of Phase 3 Clinical Trial for GMI-1271 in Relapsed/Refractory AML
Tuesday, March 06, 2018GlycoMimetics Inc announced its design for a randomized doubleblind placebocontrolled Phase clinical trial to evaluate GMI in combination with MEC Mitoxantrone etoposide and AraC or in combination with FAI fludarabine cytosine arabinoside and idarub...
Parkinson’s Institute and Clinical Center Collaborates With Denali Therapeutics to Explore New Endpoints for Clinical Studies
Tuesday, March 06, 2018The Parkinsons Institute and Clinical Center and Denali Therapeutics today announced a partnership to explore new clinical endpoints for studies in patients with Parkinsons Disease PD The Institute and Denali aim to support the development of new...
Roche achieves two major milestones in the evolution of decision support platform
Monday, March 05, 2018Roche announces two major milestones in the evolution of the Decision Support platform being developed in its Diagnostics Information Solutions DIS business The first milestone is HITRUST CSF Certifiable Security Framework certification after an a...
